Healthcare provider profile · identity verified

Lydia Smith, FNP-BC

Nurse Practitioner · SCOTT DEPOT, WV · NPI 1235415217

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Furosemide	Furosemide	330	78
Levothyroxine Sodium	Levothyroxine Sodium	325	75
Pantoprazole Sodium	Pantoprazole Sodium	284	63
Metoprolol Succinate	Metoprolol Succinate	223	62
Eliquis	Apixaban	213	45
Atorvastatin Calcium	Atorvastatin Calcium	199	52
Amlodipine Besylate	Amlodipine Besylate	191	42
Potassium Chloride	Potassium Chloride	181	48
Omeprazole	Omeprazole	176	37
Gabapentin	Gabapentin	174	38
Quetiapine Fumarate	Quetiapine Fumarate	166	27
Prednisone	Prednisone	154	58
Tramadol Hcl	Tramadol Hcl	154	39
Donepezil Hcl	Donepezil Hcl	152	25
Sertraline Hcl	Sertraline Hcl	147	31
Losartan Potassium	Losartan Potassium	144	34
Tamsulosin Hcl	Tamsulosin Hcl	140	37
Metformin Hcl	Metformin Hcl	131	25
Lisinopril	Lisinopril	130	31
Lorazepam	Lorazepam	126	33
Montelukast Sodium	Montelukast Sodium	120	22
Metoprolol Tartrate	Metoprolol Tartrate	117	25
Albuterol Sulfate Hfa	Albuterol Sulfate	110	27
Carvedilol	Carvedilol	110	25
Trazodone Hcl	Trazodone Hcl	110	26
Buspirone Hcl	Buspirone Hcl	109	25
Clopidogrel	Clopidogrel Bisulfate	103	22
Famotidine	Famotidine	102	21
Hydrochlorothiazide	Hydrochlorothiazide	101	24
Fluconazole	Fluconazole	100	34
Rosuvastatin Calcium	Rosuvastatin Calcium	98	22
Mirtazapine	Mirtazapine	94	24
Nystatin	Nystatin	93	42
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	81	14
Xarelto	Rivaroxaban	80	12
Alprazolam	Alprazolam	78	19
Duloxetine Hcl	Duloxetine Hcl	75	18
Azithromycin	Azithromycin	74	46
Torsemide	Torsemide	73	18
Bupropion Xl	Bupropion Hcl	67	13
Meloxicam	Meloxicam	64	16
Januvia	Sitagliptin Phosphate	58	13
Memantine Hcl	Memantine Hcl	58	11
Nitrofurantoin	Nitrofurantoin Macrocrystal	57	25
Oxybutynin Chloride Er	Oxybutynin Chloride	57	17
Ondansetron Hcl	Ondansetron Hcl	56	23
Citalopram Hbr	Citalopram Hydrobromide	55	13
Cephalexin	Cephalexin	51	30
Ciprofloxacin Hcl	Ciprofloxacin Hcl	51	33
Carbidopa-Levodopa	Carbidopa/Levodopa	50	11
Fluticasone Propionate	Fluticasone Propionate	50	15
Symbicort	Budesonide/Formoterol Fumarate	50	11
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	49	33
Hydralazine Hcl	Hydralazine Hcl	48	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	48	suppressed
Sucralfate	Sucralfate	48	16
Levofloxacin	Levofloxacin	47	32
Pravastatin Sodium	Pravastatin Sodium	47	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	46	14
Simvastatin	Simvastatin	46	12
Finasteride	Finasteride	45	suppressed
Spironolactone	Spironolactone	44	12
Mupirocin	Mupirocin	43	19
Myrbetriq	Mirabegron	42	suppressed
Allopurinol	Allopurinol	41	suppressed
Clonazepam	Clonazepam	41	suppressed
Pregabalin	Pregabalin	41	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	40	30
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	40	27
Divalproex Sodium	Divalproex Sodium	39	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	37	suppressed
Jardiance	Empagliflozin	34	15
Venlafaxine Hcl Er	Venlafaxine Hcl	34	suppressed
Tizanidine Hcl	Tizanidine Hcl	33	suppressed
Atenolol	Atenolol	32	suppressed
Clotrimazole	Clotrimazole	32	14
Erythromycin	Erythromycin Base	32	19
Triamcinolone Acetonide	Triamcinolone Acetonide	32	suppressed
Clonidine Hcl	Clonidine Hcl	31	suppressed
Nebivolol Hcl	Nebivolol Hcl	30	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	29	suppressed
Lidocaine	Lidocaine	28	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	27	suppressed
Lorazepam Intensol	Lorazepam	27	suppressed
Ondansetron Odt	Ondansetron	27	suppressed
Ibuprofen	Ibuprofen	26	suppressed
Metolazone	Metolazone	26	suppressed
Ozempic	Semaglutide	26	suppressed
Valsartan	Valsartan	26	suppressed
Levetiracetam	Levetiracetam	24	suppressed
Amiodarone Hcl	Amiodarone Hcl	23	suppressed
Cefdinir	Cefdinir	23	15
Fluoxetine Hcl	Fluoxetine Hcl	23	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	23	suppressed
Ventolin Hfa	Albuterol Sulfate	23	suppressed
Digoxin	Digoxin	22	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Latanoprost	Latanoprost	22	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	22	suppressed
Risperidone	Risperidone	22	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	21	suppressed
Klayesta	Nystatin	21	suppressed
Midodrine Hcl	Midodrine Hcl	21	suppressed
Ropinirole Hcl	Ropinirole Hcl	21	suppressed
Diazepam	Diazepam	20	suppressed
Ezetimibe	Ezetimibe	20	suppressed
Methotrexate	Methotrexate Sodium	20	suppressed
Calcitriol	Calcitriol	19	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Methocarbamol	Methocarbamol	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	16
Doxepin Hcl	Doxepin Hcl	17	suppressed
Fenofibrate	Fenofibrate	17	suppressed
Atropine Sulfate	Atropine Sulfate	16	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	16	suppressed
Estradiol	Estradiol	15	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Alendronate Sodium	Alendronate Sodium	14	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Cefuroxime	Cefuroxime Axetil	14	suppressed
Dulera	Mometasone/Formoterol	14	suppressed
Glimepiride	Glimepiride	14	suppressed
Glipizide	Glipizide	14	suppressed
Neomycin-Polymyxin-Hc	Neomycin/Polymyxin B/Hydrocort	14	suppressed
Ramelteon	Ramelteon	14	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	14	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Cholestyramine	Cholestyramine (With Sugar)	13	suppressed
Felodipine Er	Felodipine	13	suppressed
Icosapent Ethyl	Icosapent Ethyl	13	suppressed
Methylprednisolone	Methylprednisolone	13	suppressed
Modafinil	Modafinil	13	suppressed
Olanzapine	Olanzapine	13	suppressed
Raloxifene Hcl	Raloxifene Hcl	13	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	13	suppressed
Acetic Acid	Acetic Acid	12	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Gemfibrozil	Gemfibrozil	12	suppressed
Penicillin V Potassium	Penicillin V Potassium	12	suppressed
Rasagiline Mesylate	Rasagiline Mesylate	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	12	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	11	suppressed
Metformin Hcl Er	Metformin Hcl	11	suppressed
Nystop	Nystatin	11	suppressed
Zonisamide	Zonisamide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error